Arcis Biotechnology is a research and development led company with expertise in the development of a wide range of fast sample preparation technologies. We are based at Sci-tech Daresbury, UK, where we have fully equipped laboratory facilities. The Arcis Group has already developed a number of patented compounds and technologies that have been enthusiastically received in the commercial marketplace via our licensing partners.

Nick Ecos

CEO

Before joining Arcis Nick was CEO of Biomatrica where he led the development of biomarker collection products and the subsequent sale of the company to Exact Sciences Corporation.  He previously spent over 20 years with Life Technologies (now Thermo Fisher Scientific) as Vice President and General Manager of several global business units supplying pharma and diagnostics companies with instrument and reagent components for their gene and cell therapies and diagnostic systems.  Earlier roles included Vice President of Sales, Americas of Upstate Biotechnology (now Millipore Sigma) and before that, General Manager, Latin America of Invitrogen (now Thermo Fisher Scientific).  He holds an MBA from Harvard Business School and a B.S. from Ohio State University.

Professor Steve Howell

Non-Executive Chairman

Professor Howell has over 20 years’ life science commercialisation experience, supporting companies’ development and profitability. He founded Innova Partnerships in 2006, where he has been instrumental in creating over a dozen life science start-ups and raised in excess of £100m in financing. Steve oversaw the exit of Innova Biosciences in 2016-2017 to SYGNIS AG, Innova Partnerships’ second exit. He has held positions at Unilever plc, and was previously Director of Business Development at Alere Inc. and Research Director at Unipath Ltd. In 2015 he was made Visiting Professor of Commercial Innovation at King’s College, London.

Dr Francesco Crea

Chief Technology Officer

Dr Crea joined Arcis in June, 2020.  He most recently served as Director of Innovation and Novel Technologies at Yourgene Health (formerly Premaitha Health).  He had previously served Yourgene Health as Lead Scientist and became co-inventor of their IONA Test.  Previously he joined a team at Zoragen Biotechnologies to develop a non-invasive pre-natal test, and moved with the merger to Premaitha Health.  Prior to Zoragen he was a scientist at Oxford Immunotec. Dr Crea holds a PhD in Biotechnology from the University of Birmingham, UK, and was a Research Fellow at Warwick University.

Dr Paul Reeves

Director of R&D

Dr Reeves joined Arcis in 2015.  He is a co-inventor of the company’s patents and has led the company’s most successful technical collaborations with clients.  He was previously with Genedrive (formerly Epistem) delivering projects to the US Department of Defense and developing diagnostic platform hardware and molecular assays. Earlier Paul was with QIAGEN on a team that delivered the Therascreen range of in vitro diagnostics though the FDA PMA process and launch. Dr Reeves holds an Executive MBA from Cranfield University and a PhD in Molecular Biology from the University of Liverpool